Skip to main content
Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.770
-0.070 (-3.80%)
At close: Apr 28, 2026, 4:00 PM EDT
1.789
+0.018 (1.05%)
After-hours: Apr 28, 2026, 7:56 PM EDT

Coherus Oncology Revenue

In the year 2025, Coherus Oncology had annual revenue of $42.17M with 59.81% growth. Coherus Oncology had revenue of $12.75M in the quarter ending December 31, 2025, with 64.85% growth.

Revenue (ttm)
$42.17M
Revenue Growth
+59.81%
P/S Ratio
6.47
Revenue / Employee
$286,884
Employees
147
Market Cap
272.97M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202542.17M15.78M59.81%
Dec 31, 202426.39M-230.86M-89.74%
Dec 31, 2023257.24M46.20M21.89%
Dec 31, 2022211.04M-115.51M-35.37%
Dec 31, 2021326.55M-149.27M-31.37%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CHRS News

More News